Caxton Associates (UK)’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.76M Buy
+199,957
New +$3.84M 0.09% 84
2026
Q1
Sell
-259,406
Closed -$5.12M 766
2025
Q4
$5.12M Buy
+259,406
New +$4.66M 0.1% 65
2025
Q3
Sell
-17,132
Closed -$240K 685
2025
Q2
$240K Buy
+17,132
New +$276K 0.01% 598

Other funds holding ALHC

Caxton Associates (UK)'s ALHC Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Alignment Healthcare (ALHC) in Q2 2026: 199,957 shares worth $4.76M. The stake represents 0.09% of the portfolio and ranks #84 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in ALHC as recently as Q4 2025.

Caxton Associates (UK) first reported a position in ALHC in Q2 2025 and has held it in 3 quarters since. The position peaked at $5.12M in Q4 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Caxton Associates (UK) held 199,957 shares of Alignment Healthcare worth $4.76M as of Q2 2026.
  • Alignment Healthcare was a new Caxton Associates (UK) position in Q2 2026.
  • Alignment Healthcare made up 0.09% of Caxton Associates (UK)'s portfolio in Q2 2026, its #84 holding.
  • Caxton Associates (UK) first reported a position in Alignment Healthcare in Q2 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s Alignment Healthcare position peaked at $5.12M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.